Announce Date | 05/20/2025 |
EPS Normalized Actual | $-0.09 (Beat by $0.01) |
EPS GAAP Actual | $-0.09 (Beat by $0.01) |
Revenue Actual | $0.006945B |
Revenue Surprise | Beat by $6.945M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.1 |
EPS GAAP Estimate | $-0.1 |
Revenue Estimate | $0.006814B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0.02 | 113.5 | 0.01953441 | 0.02035495 | 1 |
Dec 2028 | 0.18 | 12.61 | 0.16711 | 0.19809 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.09 | 0.02 | 0.006945B | 22.89% | 0.56M |
FQ4 2024 (Dec 2024) | -0.2 | -0.113333 | 0.006587B | 20.18% | 0.03M |
FQ3 2024 (Sep 2024) | -0.0558 | -1.59721 | 0.006185B | 100% | -5.27M |
FQ2 2024 (Jun 2024) | -0.11 | -1.45259 | 0.005658B | 100% | -4.53M |
FQ1 2021 (Mar 2021) | -0.88 | -0.88 | 0.0024805B | 100% | 2.48M |
FQ2 2021 (Jun 2021) | -0.88 | -0.88 | 0.0024805B | 100% | 2.48M |
FQ3 2021 (Sep 2021) | -1.09 | -1.09 | 0.003078B | 100% | 3.08M |
FQ4 2021 (Dec 2021) | -0.0116 | -0.0116 | 0.003078B | 100% | 3.08M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.1
Consensus Revenue Estimates
0.006814B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | -0.04 | -- | -0.04041809 | -0.03958191 | 1 |
FQ3 2026 (Sep 2026) | -0.06 | -- | -0.06062713 | -0.05937287 | 1 |
FQ2 2026 (Jun 2026) | -0.07 | -- | -0.07073165 | -0.06926835 | 1 |
FQ1 2026 (Mar 2026) | -0.08 | -12.5 | -0.08083617 | -0.07916383 | 1 |
FQ4 2025 (Dec 2025) | -0.08 | -150 | -0.08087102 | -0.07947739 | 1 |
FQ3 2025 (Sep 2025) | -0.1 | 44.2 | -0.10348 | -0.09660389 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ3 2026 (Sep 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ2 2026 (Jun 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ1 2026 (Mar 2026) | 0.01B | 15.27 | 0.01B | 0.01B | 1 |
FQ4 2025 (Dec 2025) | 0.01B | 20.5 | 0.01B | 0.01B | 0 |
FQ3 2025 (Sep 2025) | 0.01B | 9.23 | 0.01B | 0.01B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.11 | -0.09 | 0.02 | -22.22% |
FQ4 2024 (Dec 2024) | -0.086667 | -0.2 | -0.113333 | 56.67% |
FQ3 2024 (Sep 2024) | 1.54141 | -0.0558 | -1.59721 | 2862.38% |
FQ2 2024 (Jun 2024) | 1.34259 | -0.11 | -1.45259 | 1320.54% |
FQ1 2021 (Mar 2021) | -0.88 | -0.88 | 100% | |
FQ2 2021 (Jun 2021) | -0.88 | -0.88 | 100% | |
FQ3 2021 (Sep 2021) | -1.09 | -1.09 | 100% | |
FQ4 2021 (Dec 2021) | -0.0116 | -0.0116 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.01B | $0.01B | $0.56M | 8.09% |
FQ4 2024 (Dec 2024) | $0.01B | $0.01B | $0.03M | 0.46% |
FQ3 2024 (Sep 2024) | $0.01B | $0.01B | $-5.27M | -85.27% |
FQ2 2024 (Jun 2024) | $0.01B | $0.01B | $-4.53M | -80.03% |
FQ1 2021 (Mar 2021) | $0B | $0B | $2.48M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0B | $2.48M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0B | $3.08M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0B | $3.08M | 100% |